A case of small-cell esophageal cancer with chronic renal failure undergoing hemodialysis safely treated with cisplatin and etoposide

Esophagus

Volumn 8, Issue 3, 2011, Pages 209-215

  Murakami, Kentaro ^a   Akutsu, Yasunori ^a   Miyazawa, Yukimasa ^a   Shuto, Kiyohiko ^a   Shiratori, Toru ^a   Uesato, Masaya ^a   Hoshino, Isamu ^a   Aoki, Taito ^b   Matsubara, Hisahiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Makuhari Clinic   (Japan)

Author keywords

Cisplatin; Esophagus; Etoposide; Hemodialysis; Small cell cancer

Indexed keywords

CELLULOSE TRIACETATE; CISPLATIN; ETOPOSIDE; PROGASTRIN RELEASING PEPTIDE;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER PAIN; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; COMPUTER ASSISTED TOMOGRAPHY; DECREASED APPETITE; DYSPHAGIA; ESOPHAGOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS ULCER; HEMODIALYSIS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL CELL CARCINOMA; TRACHEA CANCER;

EID: 81255158791     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-011-0284-6     Document Type: Article

References (13)

1. The Japanese Society for Esophageal Disease. Comprehensive registry of esophageal cancer in Japan (1998, 1999) and longterm results of esophagectomy in Japan (1988-1997). 3rd ed.
2. Watanabe R, Takiguchi Y, Moriya T, Oda S, Kurosu K, Tanabe N, Tatsumi K, Nagao K, Kuriyama T. Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer. Br J Cancer. 2003;88:25-30. (Pubitemid 36241213)
3. Sawada M, Okudaira M, Matsui Y, Nishiura H, Yanagida T. About the pharmacokinetics of cisplatin. Obstet Gynecol Pract. 1983;32:2117-23.
4. Tokunaga J, Kikukawa H, Nishi K, Kitani K, Fujii J, Honda J, Wada Y, Ueda S, Nakano M. Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy. Gan To Kagaku Ryoho. 2000;27:2079-85.
5. Ikeda K, Terashima M, Kawamura H, Takiyama I, Koeda K, Takagane A, Sato N, Ishida K, Iwaya T, Maesawa C, Yoshinari H, Saito K. Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administration. Jpn J Clin Oncol. 1998;28: 168-75. (Pubitemid 128525564)
6. Johnsson A, Höglund P, Grubb A, Cavallin-Ståhl E. Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous- cell carcinoma of the head/neck or esophagus. Cancer Chemother Pharmacol. 1996;39:25-33. (Pubitemid 26400657)
7. Wakui A, Yokoyama M, Takahashi H, Yoshida Y, Sakata Y, Sato S, Kano A, Kawamoto K, Hashimoto S, Konno K, et al. A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration. Gan To Kagaku Ryoho. 1986;13:319-29. (Pubitemid 17222520)
8. Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS. Increased incidence of malignancy during chronic renal failure. Lancet. 1975;19:883-6.
9. Tomita M, Aoki Y, Tanaka K. Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs. Clin Pharmacokinet. 2004;43:515-27. (Pubitemid 38858304)
10. Janus N, Thariat J, Boulanger H, Deray G, Launay-Vacher V. Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol. 2010;21:1395-403.
11. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep. 1973;4:31-42.
12. Lv J, Liang J, Wang J, Wang L, He J, Xiao Z, Yin W. Primary small cell carcinoma of the esophagus. J Thorac Oncol. 2008;3: 1460-5.
13. Aronoff GR. Drug prescribing in renal failure. 5th ed. 2007. p. 98.